BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1375120)

  • 1. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
    Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
    Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
    Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
    Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
    Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
    Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
    Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
    Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
    Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
    Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
    Shokri F; Mageed RA; Richardson P; Jefferis R
    Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
    Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
    Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism.
    Tangye SG; Weston KM; Raison RL
    Immunol Cell Biol; 1995 Feb; 73(1):44-51. PubMed ID: 7539402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
    Tangye SG; Weston KM; Raison RL
    Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
    Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
    Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.
    Drexler HG; Janssen JW; Brenner MK; Hoffbrand AV; Bartram CR
    Blood; 1989 May; 73(6):1656-63. PubMed ID: 2496772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
    Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
    Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.
    Segel GB; Woodlock TJ; Xu J; Li L; Felgar RE; Ryan DH; Lichtman MA; Wang N
    Blood Cells Mol Dis; 2003; 30(3):277-87. PubMed ID: 12737946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
    Schettino EW; Cerutti A; Chiorazzi N; Casali P
    J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia.
    Mayer R; Logtenberg T; Strauchen J; Dimitriu-Bona A; Mayer L; Mechanic S; Chiorazzi N; Borche L; Dighiero G; Mannheimer-Lory A
    Blood; 1990 Apr; 75(7):1518-24. PubMed ID: 1690580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.